ropinirole NDC 68462-253

Product information

Brand name (proprietary)

ropinirole

Generic name (nonproprietary)

ropinirole

Active ingredients

Ropinirole hydrochloride — .25 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Glenmark Pharmaceuticals Inc., USA

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 090135

Marketing start

Feb 25, 2010

Listing expires

Dec 31, 2027

Other FDA classes

Dopamine Agonists (Mechanism)

Identifiers

Product ID 68462-253_eaf797e1-337e-4fc1-bb49-29227b544fdbSPL ID eaf797e1-337e-4fc1-bb49-29227b544fdbSPL set ID 85971b31-6f7d-421c-bf3c-5b33f3c1e781RxCUI 283858, 312845, 312846, 312847, 312849, 314208, 562704UNII D7ZD41RZI9UPC 0368462258019, 0368462253014, 0368462256015, 0368462259016, 0368462254011, 0368462255018, 0368462257012

Pharmacologic class

Nonergot Dopamine Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462025301 followed by a unit qualifier and the quantity Copy

Package 68462-0253-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 090135

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.